No Data
No Data
Legend Biotech Surges Amid Takeover Speculation
Legend Biotech Rumor Highlighted in Betaville Alert
Express News | Watching Legend Biotech; Shares Spike Higher As Traders Circulate M&A Blog Comments Suggesting The Company May Be Receiving Activist Interest
RBC Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Cuts Target Price to $84
Legend Biotech Price Target Lowered to $84 From $86 at RBC Capital
BMO Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $90
廣理右汛 : Support. Sending you a block.
adaptable Otter_3218 : Ag